Malaysia files thousands of patents every year. A fraction reach the market. The gap between these two numbers is not a measurement of intellectual failure — it is a measurement of systemic failure in the commercialisation pathway. Having spent over a decade as a Director of a Technology Transfer Office and sitting on government grant evaluation boards, I have watched this gap persist, and I understand precisely why.
The problem is not the quality of Malaysian research. Our universities produce genuinely world-class innovation. The problem is the near-complete absence of structured commercialisation thinking at the point where research outputs are created. Patents are filed to satisfy KPIs. Publications are written to satisfy promotion criteria. Neither is designed with market outcomes in mind.
Why patents sit dormant
A patent is not a product. It is a legal protection for an idea. Between a protected idea and a commercially viable product sits an enormous gulf — of market validation, of investor engagement, of manufacturing readiness, of regulatory navigation, and of partnership development. In Malaysian universities, there is almost no structured support to cross this gulf.
Technology Transfer Offices exist on paper in most research institutions. In practice, they are administrative units staffed by professionals who understand IP law but not commercial strategy. The result is a growing library of protected ideas with no pathway to market.
The commercialisation rate for Malaysian university patents is not a technology problem. It is a capability and system problem — and it is entirely fixable with the right intervention.
The four barriers to commercialisation
1. Research designed without commercial intent
When research is designed to answer academic questions rather than solve industry problems, the resulting IP has limited market relevance. Commercial relevance must be designed in from the start — not retrofitted at the patent filing stage.
2. Absence of market validation
Most Malaysian patent holders have never spoken to a potential customer or industry partner before filing. The result is IP that solves problems no one is paying to have solved. Market validation — structured conversations with potential buyers and partners — must happen before significant research resources are committed.
3. No commercialisation roadmap
Even when IP has genuine commercial potential, the path from patent to product requires a structured roadmap: technology readiness assessment, licensing strategy, spinoff evaluation, industry partnership development, and investor engagement. Without this roadmap, even strong IP sits unused.
4. Inadequate industry engagement capability
Translating research into commercial language — understanding what industry partners need, how they evaluate technology opportunities, and what commercial arrangements they will consider — requires a specific capability that is almost never developed in academic environments.
The structured commercialisation pathway
At AIC, we have developed and deployed a structured commercialisation framework across Malaysian universities and R&D institutions. The framework begins before research starts — with commercial intent designed into the research question — and extends through market validation, IP positioning, partnership development, and deal structuring.
The results are measurable. Institutions that engage this framework consistently see higher rates of industry partnership, faster commercialisation timelines, and — critically — research portfolios that attract better grant funding because they can demonstrate real-world relevance from the outset.
What needs to change
Three things need to change simultaneously for the Malaysian research commercialisation rate to improve materially. First, researchers need to be trained in commercial thinking — not to become businesspeople, but to understand enough about market dynamics to design research with commercial relevance. Second, TTO professionals need structured commercialisation capability, not just IP administration skills. Third, the incentive structures in universities need to reward commercialisation outcomes, not just patent filings.
These are not aspirations. They are achievable with structured intervention. The organisations that act on this — that invest in building the commercialisation capability their IP portfolios deserve — will be the ones that define Malaysian innovation leadership over the next decade.